Neuspera is a neurotechnology company developing an implantable neuromodulation platform designed to deliver peripheral nerve stimulation without implanted batteries. The company focuses on reducing surgical burden and long-term maintenance associated with traditional implanted stimulators.

Its system consists of a miniaturized implant paired with an external wearable power source that wirelessly delivers energy and control signals. This architecture enables targeted stimulation while avoiding battery replacement surgeries and supporting flexible programming over time.

Neuspera’s technology is intended for clinical use, initially targeting pelvic health indications such as overactive bladder, with potential expansion into other peripheral neuromodulation applications. The company positions its platform as next-generation implantable neuromodulation infrastructure aimed at improving patient experience and therapy durability.